Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
February 19, 2008
Fluorescent 7-diethylaminocoumarin pyrrolobenzodiazepine conjugates: synthesis, DNA interaction, cytotoxicity and differential cellular localization
Geoffrey Wells, Marie Suggitt, Marissa Coffils, et al.
Journal of Medicinal Chemistry
|
January 22, 2005
Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents
Jane M Berry, Tracey D Bradshaw, Iduna Fichtner, et al.
Communications Biology
|
May 15, 2021
Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism
Yuta Horie, Takafumi Suzuki, Jin Inoue, et al.
Journal of Medicinal Chemistry
|
August 1, 2008
Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)
Stefania Aiello, Geoffrey Wells, Erica L Stone, et al.
Journal of Medicinal Chemistry
|
January 5, 2022
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis
Olmo Martín-Cámara, Marina Arribas, Geoffrey Wells, et al.
ACS Chemical Biology
|
March 27, 2026
Structural Studies of βTrCP Reveal Plasticity in Binding Modes of Consensus and Nonconsensus Degrons
Gavin W Collie, Hazel Mak, Marta Acebrón-García-de-Eulate, et al.
BMJ Supportive & Palliative Care
|
July 19, 2022
Cancer centre supportive oncology service: health economic evaluation
Eleanor Stewart, Simon Tavabie, Caroline McGovern, et al.
Nature Reviews. Drug Discovery
|
January 6, 2019
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Antonio Cuadrado, Ana I Rojo, Geoffrey Wells, et al.
Journal of Medicinal Chemistry
|
May 13, 2022
Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein-Protein Interaction Inhibitors with an Alternative Binding Mode
Nikolaos Georgakopoulos, Sandeep Talapatra, Dina Dikovskaya, et al.
Cancer Research
|
May 4, 2005
Elucidation of thioredoxin as a molecular target for antitumor quinols
Tracey D Bradshaw, Charles S Matthews, Jennifer Cookson, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Bioorganic & Medicinal Chemistry Letters
|
February 19, 2008
Fluorescent 7-diethylaminocoumarin pyrrolobenzodiazepine conjugates: synthesis, DNA interaction, cytotoxicity and differential cellular localization
Geoffrey Wells, Marie Suggitt, Marissa Coffils, et al.
Journal of Medicinal Chemistry
|
January 22, 2005
Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents
Jane M Berry, Tracey D Bradshaw, Iduna Fichtner, et al.
Communications Biology
|
May 15, 2021
Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism
Yuta Horie, Takafumi Suzuki, Jin Inoue, et al.
Journal of Medicinal Chemistry
|
August 1, 2008
Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)
Stefania Aiello, Geoffrey Wells, Erica L Stone, et al.
Journal of Medicinal Chemistry
|
January 5, 2022
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis
Olmo Martín-Cámara, Marina Arribas, Geoffrey Wells, et al.
ACS Chemical Biology
|
March 27, 2026
Structural Studies of βTrCP Reveal Plasticity in Binding Modes of Consensus and Nonconsensus Degrons
Gavin W Collie, Hazel Mak, Marta Acebrón-García-de-Eulate, et al.
BMJ Supportive & Palliative Care
|
July 19, 2022
Cancer centre supportive oncology service: health economic evaluation
Eleanor Stewart, Simon Tavabie, Caroline McGovern, et al.
Nature Reviews. Drug Discovery
|
January 6, 2019
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Antonio Cuadrado, Ana I Rojo, Geoffrey Wells, et al.
Journal of Medicinal Chemistry
|
May 13, 2022
Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein-Protein Interaction Inhibitors with an Alternative Binding Mode
Nikolaos Georgakopoulos, Sandeep Talapatra, Dina Dikovskaya, et al.
Cancer Research
|
May 4, 2005
Elucidation of thioredoxin as a molecular target for antitumor quinols
Tracey D Bradshaw, Charles S Matthews, Jennifer Cookson, et al.
Page
of 5